Abstract
Tocotrienol (T3) has recently gained increasing interest due to its anti-cancer effect. Here, we investigated the modulating effect of δ and γ T3 on the Ras-Raf-MEK-ERK oncogenic upstream signaling pathway in human hepatocellular carcinoma HepG2 cells. The results indicated that T3 regulated the upstream signaling cascades of this pathway.
MeSH terms
-
Carcinoma, Hepatocellular / metabolism
-
Cell Proliferation / drug effects*
-
Chromans / chemistry
-
Chromans / pharmacology*
-
Extracellular Signal-Regulated MAP Kinases / genetics
-
Extracellular Signal-Regulated MAP Kinases / metabolism
-
Gene Expression Regulation, Enzymologic / drug effects
-
Gene Expression Regulation, Neoplastic / drug effects*
-
Hep G2 Cells
-
Humans
-
Liver Neoplasms / metabolism
-
MAP Kinase Kinase Kinases / genetics
-
MAP Kinase Kinase Kinases / metabolism
-
Signal Transduction / drug effects
-
Vitamin E / analogs & derivatives*
-
Vitamin E / chemistry
-
Vitamin E / pharmacology
-
raf Kinases / genetics
-
raf Kinases / metabolism*
-
ras Proteins / genetics
-
ras Proteins / metabolism*
Substances
-
Chromans
-
Vitamin E
-
tocotrienol, delta
-
plastochromanol 8
-
raf Kinases
-
Extracellular Signal-Regulated MAP Kinases
-
MAP Kinase Kinase Kinases
-
ras Proteins